Pavletic SZ - Search Results

1

Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease.

Schulz E, Pirsl F, Holtzman NG, Beshensky D, Cowen EW, Mitchell SA, Steinberg SM, Pavletic SZ. Schulz E, et al. Among authors: pavletic sz. Haematologica. 2024 Jan 1;109(1):298-302. doi: 10.3324/haematol.2023.283646. Haematologica. 2024. PMID: 37584292 Free PMC article. No abstract available.

2

Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes.

Schulz E, Aplan PD, Freeman SD, Pavletic SZ. Schulz E, et al. Among authors: pavletic sz. Blood Adv. 2023 Aug 22;7(16):4381-4394. doi: 10.1182/bloodadvances.2023010098. Blood Adv. 2023. PMID: 37267435 Free PMC article.

3

W"H-Y" antigen/HLA complexes in chronic GVHD.

Holtzman NG, Pavletic SZ. Holtzman NG, et al. Among authors: pavletic sz. Blood. 2023 Sep 14;142(11):946-948. doi: 10.1182/blood.2023021357. Blood. 2023. PMID: 37707875 Free PMC article. No abstract available.

4

Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study.

Mitchell SA, Hunter R, Fry A, Pavletic SZ, Widemann BC, Wiener L. Mitchell SA, et al. Among authors: pavletic sz. Front Psychol. 2024 Jan 8;14:1243005. doi: 10.3389/fpsyg.2023.1243005. eCollection 2023. Front Psychol. 2024. PMID: 38259542 Free PMC article.

5

Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.

Rosenstein RK, Rose JJ, Brooks SR, Tsai WL, Gadina M, Pavletic SZ, Nagao K, Cowen EW. Rosenstein RK, et al. Among authors: pavletic sz. JID Innov. 2023 Dec 7;4(2):100246. doi: 10.1016/j.xjidi.2023.100246. eCollection 2024 Mar. JID Innov. 2023. PMID: 38357212 Free PMC article.

6

Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges.

Schulz E, Pavletic SZ, Mina A. Schulz E, et al. Among authors: pavletic sz. Semin Hematol. 2024 Dec;61(6):420-430. doi: 10.1053/j.seminhematol.2024.10.004. Epub 2024 Oct 17. Semin Hematol. 2024. PMID: 39523201 Review.

7

Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease.

McManus T, Holtzman NG, Zhao A, Cousineau-Krieger C, Vitale S, FitzGibbon EJ, Payne D, Newgen J, Igbinosun C, Im AP, Peer C, Figg WD Sr, Cowen EW, Mays JW, Pavletic S, Magone MT. McManus T, et al. Ophthalmol Sci. 2024 Sep 30;5(1):100627. doi: 10.1016/j.xops.2024.100627. eCollection 2025 Jan-Feb. Ophthalmol Sci. 2024. PMID: 39605875 Free PMC article.

8

Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective.

Mariotti J, Fowler DH, Bramanti S, Pavletic SZ. Mariotti J, et al. Among authors: pavletic sz. Front Immunol. 2023 May 15;14:1212756. doi: 10.3389/fimmu.2023.1212756. eCollection 2023. Front Immunol. 2023. PMID: 37256121 Free PMC article. No abstract available.

9

The evolution of preclinical models for myelodysplastic neoplasms.

Mina A, Pavletic S, Aplan PD. Mina A, et al. Leukemia. 2024 Apr;38(4):683-691. doi: 10.1038/s41375-024-02181-2. Epub 2024 Feb 23. Leukemia. 2024. PMID: 38396286 Free PMC article. Review.

10

A contemporary downtrend in chronic GVHD?

El Jurdi N, Pavletic SZ. El Jurdi N, et al. Among authors: pavletic sz. Blood Adv. 2024 Nov 26;8(22):5875-5877. doi: 10.1182/bloodadvances.2024014586. Blood Adv. 2024. PMID: 39546299 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters